Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

JSON

Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, Ferrari V, Ciampi D, Ilonen I, Räsänen J, Mäyränpää M, Partanen J, Koskela S, Kuryk L, Russo S, Fusciello M, Hamdan F, Rescigno M, Grönholm M, Branca RM, Lehtiö J, Cerullo V

- - (-) - [2022-11-08; online 2022-11-08]

DOI 10.21203/rs.3.rs-2238403/v1

Crossref 10.21203/rs.3.rs-2238403/v1